Steven A Porcelli

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 173(Granted Patents)

Location History:

Brighton, MA (US) (1997 - 1998)
Bronx, NY (US) (2001 - 2015)
Hartsdale, NY (US) (2016 - 2018)

Company Filing History:

8 out of 504

Albert Einstein College of Medicine

patents

4 out of 1,384

The Brigham and Women's Hospital, Inc.

University of California

patents

5. 1 out of 470

Colorado State University Research Foundation

patents

6. 1 out of 1,274

The University of North Carolina at Chapel Hill

patents

where one patent can have more than one assignee

Years Active: 1997-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10111950 - Modified glycolipids and methods of making and using the same (2018-10-30),

2. 9371352 - Modified glycolipids and methods of making and using the same (2016-06-21),

3. 9139809 - Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof (2015-09-22),

4. 8591918 - Mycobacterial mutants inducing IL-12 (2013-11-26),

5. 8394388 - Mycobacterial mutants affecting host apoptosis (2013-03-12),

6. 8101191 - Mycobacterial SecA2 mutants (2012-01-24),

7. 8022043 - Ceramide derivatives as modulators of immunity and autoimmunity (2011-09-20),

8. 7772380 - Ceramide derivatives as modulators of immunity and autoimmunity (2010-08-10),

9. 7063844 - Presentation of hydrophobic antigens to T-cells by CD1 molecules (2006-06-20),

10. 6238676 - Presentation of hydrophobic antigens to T-cells by CD1 molecules (2001-05-29),

11. 5853737 - Method for inducing a CD1-restricted immune response (1998-12-29),

12. 5679347 - Methods of isolating CD1-presented antigens, vaccines comprising (1997-10-21),

Title: The Innovative Work of Inventor Steven A Porcelli

Introduction

Steven A Porcelli, a talented inventor hailing from Bronx, NY, has made significant contributions to the field of bacterial vaccines and immunology. With an impressive portfolio of 10 patents under his belt, Porcelli's cutting-edge research has paved the way for groundbreaking advancements in disease prevention and treatment.

Latest Patents

Porcelli's latest patents showcase his expertise in developing innovative solutions for combating infectious diseases. One of his recent inventions focuses on bacterial vaccines with cell wall-associated ceramide-like glycolipids. This novel approach allows for the targeted delivery of adjuvants to infected cells, enhancing the efficacy of vaccines in preventing and treating diseases.

Another noteworthy patent by Porcelli involves mycobacterial mutants that induce IL-12 production. By manipulating specific gene clusters and mutations in mycobacteria, Porcelli has engineered vaccines that can modulate immune responses in mammals. These advancements hold great promise for improving vaccine development and enhancing immune system function.

Career Highlights

Throughout his career, Porcelli has worked with prestigious institutions such as the Albert Einstein College of Medicine of Yeshiva University and The Brigham and Women's Hospital, Inc. His collaborations with leading medical centers have provided him with valuable resources and expertise to further his research efforts.

Collaborations

Porcelli has had the privilege of collaborating with esteemed colleagues in the field of immunology. Notable coworkers include Michael B Brenner and Evan M Beckman, who have contributed to Porcelli's research endeavors with their own expertise and insights. Together, they have formed a dynamic team dedicated to advancing the frontiers of vaccine development.

Conclusion

Inventor Steven A Porcelli's remarkable work in the field of bacterial vaccines and immunology underscores his commitment to innovation and scientific excellence. His groundbreaking patents and collaborations have positioned him as a key figure in the fight against infectious diseases, leaving a lasting impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.